Financials
- Market Capitalization 9.03 B
- Employee 141
- Founded 2006
- CEO N/A
- Website www.protagonist-inc.com
- Headquarter Delaware, United States
- FIGI BBG002B63KM7
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-42.6
売上高対価格比率
120.66
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 894 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.66 USD | -0.73% | +3.32% | +0.99% | +98.41% | 10.01 B USD | ||
| 920 | KRYS Krystal Biotech, Inc. - Common Stock | 322.57 USD | -2.86% | -0.61% | -8.03% | +72.38% | 9.55 B USD | ||
| 955 | KYMR Kymera Therapeutics, Inc. - Common Stock | 107.14 USD | -4.41% | +2.80% | -7.64% | +81.29% | 8.91 B USD | ||
| 970 | CYTK Cytokinetics, Incorporated - Common Stock | 61.83 USD | -1.53% | +0.95% | -15.89% | +6.42% | 8.60 B USD |